Fortress Biotech, Inc. (NASDAQ: FBIO) had its price target raised by analysts at HC Wainwright from $24.00 to $26.00. They now have a "buy" rating on the stock.
Fortress Biotech Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Fortress Biotech, Inc. (NASDAQ: FBIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer [Yahoo! Finance]
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]